ctrl K

Price Alert

Karyopharm Therapeutics I... (KPTI)

NASDAQ: KPTI · Real-Time Price · USD

5.96

1.31 (28.17%)

At close: Aug 15, 2025, 3:59 PM

5.60

-6.01%

After-hours: Aug 15, 2025, 07:58 PM EDT

Karyopharm Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	62.48M	52.23M	135.19M	190.46M
Short-Term Investments	46.24M	139.21M	142.78M	38.16M
Long-Term Investments	308K	301K	633K	637K
Other Long-Term Assets	1.33M	1.33M	n/a	27.42M
Receivables	30.77M	26.96M	47.09M	22.5M
Inventory	4.74M	3.04M	4.22M	4.11M
Other Current Assets	12.28M	12.47M	8.86M	6.35M
Total Current Assets	156.49M	233.92M	350.16M	275.61M
Property-Plant & Equipment	6.28M	4.88M	7.38M	1.64M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.93M	6.52M	8.01M	29.7M
Total Assets	164.42M	240.44M	358.17M	305.31M
Account Payables	5.11M	3.12M	2.77M	1.6M
Deferred Revenue	n/a	n/a	n/a	69.12M
Short-Term Debt	24.43M	3.31M	2.87M	2.32M
Other Current Liabilities	62.29M	43.23M	37.77M	-21.32M
Total Current Liabilities	92.26M	69.48M	65.91M	73.72M
Long-Term Debt	162.95M	170.92M	170.1M	169.29M
Other Long-Term Liabilities	15.01M	978K	132.72M	133M
Total Long-Term Liabilities	258.17M	307.17M	308.92M	311.26M
Total Liabilities	350.44M	376.64M	374.83M	384.98M
Total Debt	194.52M	177.02M	179.07M	180.58M
Common Stock	13K	12K	12K	8K
Retained Earnings	-1.56B	-1.49B	-1.34B	-1.18B
Comprehensive Income	-356K	-161K	-638K	191K
Shareholders Equity	-186.02M	-136.21M	-16.66M	-79.67M
Total Investments	46.24M	139.21M	142.78M	38.16M